---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-270314"
form_type: "8-K"
ticker: "BEAM"
cik: "0001745999"
company_name: "Beam Therapeutics Inc."
filed_at: "2024-12-04T23:59:59+00:00"
generated_at: "2026-05-29T08:46:14.654790+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Beam Therapeutics appoints Chirfi Guindo to board of directors

## Summary
- Chirfi Guindo, chief marketing officer of Human Health at Merck, appointed to Beam's board.
- Board expanded from seven to eight members; Guindo elected as Class I director effective Dec. 2, 2024.
- Guindo brings 25+ years at Merck and Biogen, expertise in global strategy and commercial operations.
- He will serve on the Compensation Committee of the board.

## SEC filing metadata
- accession: 0001193125-24-270314
- form_type: 8-K
- ticker: BEAM
- cik: 0001745999
- company_name: Beam Therapeutics Inc.
- filed_at: 2024-12-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1745999/000119312524270314/0001193125-24-270314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1745999/000119312524270314/d912801d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-270314
- JSON: https://secwatch.observer/filing/0001193125-24-270314.json
- Plain text: https://secwatch.observer/filing/0001193125-24-270314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.